Our Work

Human tissue is a precious gift when donated with the unselfish hope that it may enhance another life. At Alaris, we honor the gift of tissue donation by striving to create tissue products that make a difference to patients and meet the surgeon’s demanding expectations.

Allograft Safety

Donors are screened using a comprehensive series of serological and microbiological tests, coupled with a determination of donor eligibility and suitability by a Medical Director prior to release of any tissue for implantation. In addition, in-process tests are conducted consistent and compliant with with FDA Regulations 21 CFR 1270 and 1271.

eBeam Sterilization Technology (e10-6)

Alaris utilizes eBeam technology, a validated process for sterilizing bone tissue. Ebeam sterilization is regarded as one of the least damaging and tissue sparing methods to achieve 10-6 sterility assurance.

Gamma Sterilization Technology (r10-6)

Alaris utilizes gamma irradiation to sterilize certain bone products. The sterilization is performed to achieve 10-6 sterility assurance while minimizing potential damage to the tissue that could compromise performance. 


Alaris utilizes a validated aseptic process for production of Allograft Fluid. This process is performed with rigorous environmental controls and products tested in accordance with USP <71>.



Bone grafts are processed using chemicals that have a long history of safe and effective use in tissue processing. Our validated processes cleanse the tissue while preserving critical biologic and structural elements needed for optimal graft performance.

Reconstructive allograft bone selections:

(Multiple sizes available)

  • Cancellous Crushed
  • Demineralized Cube
  • Demineralized Strip
  • Demineralized Paste
  • Demineralized Putty
  • Iliac Crest Wedge

Soft Tissue Allografts

The soft tissue grafts are processed to preserve the tissue structure and integrity while mitigating the slight risk of disease transmission. No measurable degradation or loss in mechanical properties occur during soft tissue processing.

The soft tissue grafts can be utilized in several clinical applications including ACL, MCL, and PCL repair. In addition, complete lines of pre-sized bone-tendon-bone (BTB) grafts and Achilles tendon grafts are available.

Reconstructive soft tissue allograft selections: (Multiple sizes available)

  • Achilles Tendons (can pre-size to 10mm)
  • Gracilis Tendons
  • Patella Tendons (can pre-size to 10mm)
  • Peroneus Longus Tendons
  • Semitendinosus Tendons
  • Tibialis Tendons
Tissue Grafts

Protein PreservedAllograft Patch

Durable Biologic Wound Cover
The Protein PreservedAllograft Patch is a dual layer amniotic membrane comprised of the unique extracellular collagen matrix that makes up the amnion basement membrane. It is the strongest basement membrane in the body and can be used in a variety of wound care applications requiring a wound cover or adhesion barrier.  

The use of membrane has demonstrated potential applications in the following areas:

  • Adhesion Barrier
  • Chronic Wounds
  • Reduction of Scar Tissue Formation
  • Nerve Bundle and Peripheral Wrap
  • Periodontal Guided Tissue Regeneration
  • Dermal Burns


Liquid Allograft

The liquid allograft is an alternative product for injury and wound management. Intended for homologous use, it is a non-structural decellularized fluid allograft produced from amniotic fluid. Liquid allograft contains growth factors and anti-inflammatory cytokines that are believed to have a beneficial effect on wound healing.

Potential Clinical Applications

As a unique alternative to invasive surgical procedures it has a variety of potential applications that may include:

  • Tendonitis
  • Reduction of scarring
  • Chronic wound covering
  • Soft tissue or bone trauma
  • Localized inflammation

The liquid allograft is processed using a proprietary amniotic fluid purification process, which allows for rapid retrieval of fluid without compromising protein integrity.  All liquid allograft is tested for sterility according to USP <71>.


About Us

Dedicated to Advancing Human Healing

Alaris is a biologic technologies company that is focused on advancing human healing. We boast one of the most experienced and respected teams in the industry, and employ tissue processing technologies that meet or exceed industry standards to insure allograft quality and safety.

Alaris, founded in 2013 as Amniolife, is a portfolio company of Fountainhead Investment Partners. The company offers a selection of human-derived products, including (sports medicine) soft tissue grafts, bone and birth tissue biologics, and serves as a contract manufacturer of biologic products for distributors.


Alaris products are available to doctors and hospitals through a selected list of distributors currently focused in the United States. Contact us for the distributor in your area.

Alaris is highly selective in determining our distributor network partnerships. We look for distributors with recognized high quality service delivery. If you are interested in learning more about joining the Alaris distribution network, please contact us.

News & Events

April 27, 2017